drugset / Trial / NCT04330079
Effects of dapaglifloziN Therapy on Myocardial Perfusion Reserve in Prediabetic Patients With Stable coronarY Artery Disease
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the effects of dapagliflozin therapy on myocardial perfusion reserve (MPR) using dynamic SPECT examination in prediabetic patients with stable CAD. Dapagliflozin therapy versus lifestyle modification improves myocardial perfusion reserve in prediabetic patients with stable CAD.
Timeline
- Start
- 2020-05-21
- Primary completion
- 2021-04-08
- Completion
- 2021-04-08
Outcome
Outcome not reported
Stopped (Enrollment): “Slow enrollment. (Difficulty in selecting subjects)”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapagliflozin | Small molecule | 10 mg | — |